Balancing Bleeding and Clotting Risks: Updated LP Guidelines in Antithrombotic Care- by Dr. Chokri Ben Lamines
Updated Peri-Procedural Guidelines at a Glance on X։
Explore Dr. Chokri Ben Lamine’s evidence-based guide on safely performing lumbar puncture in patients receiving anticoagulants or antiplatelet therapy. This concise reference outlines when to pause, bridge, or proceed—based on the latest international recommendations․
“Lumbar Puncture & Bleeding Risk: Summary
-When to stop or continue common agents (aspirin, warfarin, DOACs)
-Risk stratification for bleeding vs. thrombosis
-Bridging protocols for high-risk patients
-Practical timing for safe LP executionStop Antithrombotics Before LP
Antiplatelets
• Aspirin 75mg: Continue
• Clopidogrel: 7d (aspirin cover) → LP after 6h
• Prasugrel/Ticagrelor: 7d → LP after 6h
• Dipyridamole: 24h → LP after 6h
• Tirofiban/Eptifibatide: 4–8h → LP after 4h
• Abciximab: 48h → LP after 24hAnticoagulants
• Warfarin: 5d → INR ≤1.4 → LP → restart 12h
• LMWH (proph): 12h → LP → restart 4h
• LMWH (Tx): 24h → LP → restart 4h (24h if traumatic)
• Fondaparinux (proph): 36h → LP → restart 6–12h
• Fondaparinux (Tx): Avoid LP
• UFH IV: –6h → LP → restart 1h
• Rivaroxaban/Apixaban: 24h → LP → restart 6h
• Dabigatran: 48h → LP → restart 6h”
For fast answers to nuanced clinical questions, visit Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?